Evidence map›Paper›PMID 27977083›Full record

ArticleHealth promotion and chronic disease prevention in Canada : research, policy and practice2016

The 2014 Survey on Living with Chronic Diseases in Canada on Mood and Anxiety Disorders: a methodological overview.

S O'Donnell, R Cheung, K Bennett, C Lagacé

Abstract read
In one paragraph

Article in Health promotion and chronic disease prevention in Canada : research, policy and practice, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Introduction.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2017
    Article
  3. Factors associated with delayed diagnosis of mood and/or anxiety disorders.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2017
    Article
  4. Use of medication and psychological counselling among Canadians with mood and/or anxiety disorders.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2017
    Article
  5. Health status, activity limitations, work-related restrictions and level of disability among Canadians with mood and/or anxiety disorders.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2016
    Article
  6. Correlates of well-being among Canadians with mood and/or anxiety disorders.Health promotion and chronic disease prevention in Canada : research, policy and practice · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

S O'DonnellPublic Health Agency of Canada, Ottawa, Ontario, Canada.
R CheungPublic Health Agency of Canada, Ottawa, Ontario, Canada.
K BennettDepartment of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
C LagacéPublic Health Agency of Canada, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThere is a paucity of information about the impact of mood and anxiety disorders on Canadians and the approaches used to manage them. To address this gap, the 2014 Survey on Living with Chronic Diseases in Canada-Mood and Anxiety Disorders Component (SLCDC-MA) was developed. The purpose of this paper is to describe the methodology of the 2014 SLCDC-MA and examine the sociodemographic characteristics of the final sample.

methodsThe 2014 SLCDC-MA is a cross-sectional follow-up survey that includes Canadians from the 10 provinces aged 18 years and older with mood and/or anxiety disorders diagnosed by a health professional that are expected to last, or have already lasted, six months or more. The survey was developed by the Public Health Agency of Canada (PHAC) through an iterative, consultative process with Statistics Canada and external experts. Statistics Canada performed content testing, designed the sampling frame and strategies and collected and processed the data. PHAC used descriptive analyses to describe the respondents' sociodemographic characteristics, produced nationally representative estimates using survey weights provided by Statistics Canada, and generated variance estimates using bootstrap methodology.

resultsThe final 2014 SLCDC-MA sample consists of a total of 3361 respondents (68.9% response rate). Among Canadian adults with mood and/or anxiety disorders, close to twothirds (64%) were female, over half (56%) were married/in a common-law relationship and 60% obtained a post-secondary education. Most were young or middle-aged (85%), Canadian born (88%), of non-Aboriginal status (95%), and resided in an urban setting (82%). Household income was fairly evenly distributed between the adequacy quintiles; however, individuals were more likely to report a household income adequacy within the lowest (23%) versus highest (17%) quintile. Forty-five percent reported having a mood disorder only, 24% an anxiety disorder only and 31% both kinds of disorder.

conclusionThe 2014 SLCDC-MA is the only national household survey to collect information on the experiences of Canadians living with a professionally diagnosed mood and/or anxiety disorder. The information collected offers insights into areas where additional support or interventions may be needed and provides baseline information for future public health research in the area of mental illness.

Indexed as

AdolescentAdultAgedAge FactorsAnxiety DisordersCanadaChronic DiseaseCross-Sectional StudiesEducational StatusFemaleFollow-Up StudiesHealth SurveysHumansIncomeMaleMarital Statusanxiety disordersdisease managementhealth surveysmental health impactsmood disorderspopulation surveillancesurvey methodologysurvey on Living with Chronic Diseases in Canada

Identifiers

PMID27977083
PMCPMC5387795

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.